Advertisement

Topics

Companies Related to "Amgen Announces Voting Results Annual Meeting Stockholders" [Most Relevant Company Matches] RSS

03:00 EDT 19th September 2018 | BioPortfolio

Here are the most relevant search results for "Amgen Announces Voting Results Annual Meeting Stockholders" found in our extensive corporate database of over 50,000 company records.

Showing "Amgen Announces Voting Results Annual Meeting Stockholders" Companies 1–25 of 1,900+

Relevant

Amgen Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight agai...


Amgen, Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight agai...

Amgen

The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative wa...


Amgen AB

Amgen är ett världsledande bioteknologiskt läkemedelsföretag. Genom vetenskapliga upptäckter och innovationer har företaget under 25 års tid bidragit till att radikalt förbättra människors liv. Amgen är föregångare i utvecklingen av nya produkter baserade på rekombinant DNA-teknik och molekylärbiologi och stod för lanseringen av bioteknikindustrins första storsäljande läkemedel....

bluebird bio, Inc. bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting

Amgen Inc

Amgen is a leading human therapeutics company in the biotechnology industry. For 25 years, the company has tapped the power of scientific discovery and innovation to dramatically improve people’s lives.Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fo...

Bloomingdale Telephone Company Inc.

Bloomingdale Telephone Company, Inc. is a Michigan corporation established in 1955 for the purpose of providing telecommunications services and has been evolving ever since. Operating as a privately held stock corporation, the company provides along with its subsidiary Bloomingdale Communications, Inc. a wide range of services throughout the southwest Michigan area. Each year the stockholders hold...

Concerned Osteotech Stockholders

The Participants of the Concerned Osteotech Stockholders are Heartland Advisors, Inc., Spencer Capital Opportunity Fund, LP, Spencer Capital Management, LLC, Spencer Capital Partners, LLC, Boston Avenue Capital LLC, Gary L. Alexander, Michelle Rachael Forrest, Michael J. McConnell and Kenneth H. Shubin Stein, M.D.

Amgen Incorporated

Over the past quarter century, Amgen has pioneered the methods by which human proteins that play a role in disease processes are identified, isolated, produced in quantity and used as therapeutics. Today, Amgenhas research programs in inflammation, metabolic disorders and osteoporosis, neurology, oncology and hematology. The company has R&D facilities in Thousand Oaks, CA; San Francisco, CA; Cambr...

American College of Neuropsychopharmacology

The Annual Meeting is one of the world's leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs. The Annual Meeting provides an opportunity to:attend an outstanding scientific program in clinical and basic research on brain-behavior-drug interactions; learn about the most recent, and often unpublished, advances in psychopharmacology...

Philweb Corp

Philweb Corp. will launch three text-based gaming projects this year to take advantage of a partnership with ePLDT, a wholly-owned unit of the Philippine Long Distance Telephone Co.ilweb Chairman and former trade minister Roberto Ongpin said during the company's annual stockholders' meeting that the company would launch today it's first text-based product, called " Premyo sa Resibo. "The program, ...

SRS Technologies

SRS Technologies, since its founding in 1970, has become a dynamic engineering company providing diversified Information Technology Services and Products to Government and commercial customers on a worldwide basis. SRS' mission is: a) to provide the very best services in System Engineering, System Integration and Information Technologies; b) to foster continuous innovation and performance improvem...

Prolucent Workforce Management

Visit Prolucent at Booth #834 at AONE’s 43rd Annual Meeting and Exposition

Yara International

Yara reports strong financial results for the second quarter 2006 and clearly establishes itself as the second largest fertilizer company in Brazil, through the acquisition of the fertilizer and distribution company, Fertibras.Yara has acquired 48.09 percent of the shares in Fertibras for USD 126 million. This represents 99.95 percent of voting shares and Fertibras will therefore be consolidated i...

Norsk Biokjemisk Selskap

The Norwegian Biochemical Society (NBS) was established in 1964 and aims to be a scientific and social forum for scientists and students of biology in Norway. In addition, we have ambitions of becoming an influential actor in national science politics. Membership is open to anyone. The membership fee is low and especially low for students. We have personal as well as corporate memberships, about 1...

EPSA

In the Spring of 1978, the "Association Nationale des Etudiants en Pharmacie de France" invited a group of students from various European countries to their congress held in Nancy,France. The reason for this meeting was to discuss the forthcoming European Community, EC, directives on the mutual recognition of pharmacy diplomas within the European Community, and to compare pharmacy studies in the d...

Care Investment Trust Inc.

The complete terms and conditions of the tender offer are set forth in the Offer to Purchase and Letter of Transmittal that are being sent to Care's stockholders. Stockholders are urged to read the tender offer documents carefully when they become available. Copies of the Offer to Purchase, Letter of Transmittal and other related materials may be obtained at Care's expense from the information age...

Annual Reviews

Since 1932, Annual Reviews has offered comprehensive, timely collections of critical reviews written by leading scientists. Annual Reviews volumes are published each year for 32 focused disciplines within the Biomedical, Physical, and Social Sciences. Annual Reviews is a nonprofit organization whose mission is to provide the worldwide scientific community with a useful and intelligent synthesis of...

BioAlabama

WHAT:2012 Annual Meeting featuring Gov. Robert Bentley, an update of the BioAlabama Five Year Strategic Plan and presentation of Biotechnology Resolution by Sen. Jabo Waggoner and Rep. Phil Williams.

The Hub, LLC

The Hub is the foremost destination for off-site corporate meetings and events, offering comfortable, stylish, convenient, private and reasonably priced meeting space, top-level service and exclusive catering by STARR Events. The company also offers offsite meeting management around the world, as well as facilities management of public or private meeting centers. Built upon a foundation of corpora...

Vasogen

We are focused on the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease. The recently completed international 2,400-patient ACCLAIM trial assessed the impact of our Celacade™ technology on reducing the risk of mortality and morbidity in patients with advanced heart failure. Full results for the ACCLAIM study ...

SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited was established in March, 2005 by Fuminori Yoshida who previously served concurrently as Corporate VP of Amgen Inc. and founding President of Amgen Japan. In May, 2016 SymBio incorporated its wholly-owned subsidiary in the U.S., SymBio Pharma USA, Inc. (Headquarters: Menlo Park, California, President: Mr. Fuminori Yoshida). S...

SU2C/Amgen

Sterling Institutional Review Board

Currently Sterling IRB has several hundred studies under review. These studies involve both single investigators and multi-investigator protocols. Sterling has experience working with many of the largest pharmaceutical companies, as well as some of the smallest. Sterling works closely with both small, local and large, national contract research organizations. The Sterling Board is broad-based, wit...

Dolphin Meeting

Dolphin provides quality imaging, diagnostic and management solutions for dental-specialty practices and institutions. An industry leader since 1988, we offer advanced software solutions and unrivalled service. Our products have always been based on an “open platform.” This enables other complimentary products and services to integrate innovative solutions to increase and enhance the efficienc...


More From BioPortfolio on "Amgen Announces Voting Results Annual Meeting Stockholders"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks